PJSC Farmak pharmaceutical company (Kyiv) has raised a five-year loan from the European Bank for Reconstruction and Development (EBRD) in the amount of EUR 15 million (equivalent of UAH 427.838 million)
An Interfax-Ukraine correspondent has reported that the loan agreement was signed between the bank and the pharmaceutical producer on Tuesday.
Farmak Executive Director Volodymyr Kostiuk said that the company has raised around EUR 72 million from the EBRD since 2006.
"The EBRD is our strategic partner, we will continue working with it," he said.
Kostiuk said that the attracted funds are intended to expand production at the Farmak's facility in Kyiv.
"We want to develop and conquer new markets, but today we do not have enough production capacity, so the expansion of production is very important for us," he said.
The borrowed funds will be sent, in particular, to finance the expansion of production facilities, and the construction of a new laboratory and production complex.
Advertising
Advertising
MORE ABOUT
EBRD provides Credit Agricole Bank EUR 150 mln guarantee for business lending
09:57, 03.12.2025
EBRD to provide Ukrhydroenergo EUR 75 mln, expects additional EUR 20 mln in investment grants
20:34, 02.12.2025
EBRD provides guarantee for Ukrsibbank loan to develop EVA logistics hubs
13:36, 26.11.2025
Ukrainian pharma manufacturers lose 3-5% of revenues due to state regulation – expert
11:10, 18.11.2025
IFC and EBRD co-invest $25 mln in Dragon Capital's Rebuild Ukraine Fund
11:55, 14.11.2025
LATEST
Ukraine's State Agency revises claims about UAH 6.6 bln road through Bukovel
20:30, 05.12.2025
G7, EU countries considering complete ban on oil transportation from Russia instead of price cap – media
20:29, 05.12.2025
Intl support for humanitarian demining since 2022 reaches nearly $1.5 bln – Economy Minister
19:42, 05.12.2025
Eighty-three candidates apply for four Energoatom Supervisory Board seats
14:02, 05.12.2025
Vodafone Ukraine announces another buy-out of eurobonds for $1.16 mln